Suppr超能文献

肾功能正常患者的钙过敏症

Calciphylaxis in Patients With Preserved Kidney Function.

作者信息

Maroz Natallia, Mohandes Samer, Field Halle, Kabakov Zlata, Simman Richard

机构信息

Renal Physicians Inc., Dayton, OH, USA ; Department of Medicine, Wright State University, Boonshoft School of Medicine, Dayton, OH, USA.

Department of Medicine, Wright State University, Boonshoft School of Medicine, Dayton, OH, USA ; Miamy Valley Hospital, Dayton, OH, USA.

出版信息

J Am Coll Clin Wound Spec. 2015 Aug 7;6(1-2):24-8. doi: 10.1016/j.jccw.2015.08.002. eCollection 2014 Apr.

Abstract

Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is a devastating disease typically seen in patients with end stage renal disease. It manifests as extremely painful symmetrical wounds resistant to surgical and medical interventions. The prevalence of CUA among hemodialysis dependent patients was found to be as high as 4.1%. The management of patients with CUA requires a multidisciplinary approach by the medical team, yet often results in a low rate of successful outcomes. Recently, non-uremic calciphylaxis (NUC) has been described in the absence of kidney disease. Limited knowledge exists on the management of NUC and the outcomes of this condition. Herein we describe three clinical scenarios of patients diagnosed with NUC in the absence of permanent or prolonged acute renal pathology. The reporting of successful and fruitless therapeutic interventions for wound management in NUC is important for compiling the evidence of effective therapeutic strategies.

摘要

钙化性尿毒症小动脉病(CUA),也称为钙化防御,是一种典型见于终末期肾病患者的毁灭性疾病。它表现为对手术和药物干预均有抵抗的极其疼痛的对称性伤口。在依赖血液透析的患者中,CUA的患病率高达4.1%。CUA患者的管理需要医疗团队采取多学科方法,但往往成功率较低。最近,在无肾脏疾病的情况下描述了非尿毒症性钙化防御(NUC)。关于NUC的管理及这种情况的预后,目前了解有限。在此,我们描述了3例在无永久性或长期急性肾脏病变情况下被诊断为NUC的患者的临床病例。报告NUC伤口管理中成功和无效的治疗干预措施对于汇编有效治疗策略的证据很重要。

相似文献

1
Calciphylaxis in Patients With Preserved Kidney Function.
J Am Coll Clin Wound Spec. 2015 Aug 7;6(1-2):24-8. doi: 10.1016/j.jccw.2015.08.002. eCollection 2014 Apr.
4
Multidisciplinary approach to calcific uremic arteriolopathy.
Curr Opin Nephrol Hypertens. 2015 Nov;24(6):531-7. doi: 10.1097/MNH.0000000000000175.
5
Calcific Uremic Arteriolopathy in End-Stage Renal Disease: A Rare Life-Threatening Condition.
Cureus. 2023 Oct 30;15(10):e48002. doi: 10.7759/cureus.48002. eCollection 2023 Oct.
6
Multi-intervention management of calcific uremic arteriolopathy in 24 patients.
Clin Kidney J. 2018 Oct;11(5):704-709. doi: 10.1093/ckj/sfy007. Epub 2018 Mar 9.
8
Non-Uremic Calciphylaxis: A Rare Diagnosis with Limited Therapeutic Strategies.
Eur J Case Rep Intern Med. 2018 Dec 27;5(12):000986. doi: 10.12890/2018_000986. eCollection 2018.
10
Sodium thiosulfate is effective in calcific uremic arteriolopathy complicating chronic hemodialysis.
Joint Bone Spine. 2016 Jan;83(1):89-92. doi: 10.1016/j.jbspin.2015.03.007. Epub 2015 Oct 19.

引用本文的文献

3
Non-uremic calciphylaxis in a woman without end-stage renal disease.
BMJ Case Rep. 2021 Feb 26;14(2):e239225. doi: 10.1136/bcr-2020-239225.
4
Non-uraemic calciphylaxis successfully treated with pamidronate infusion.
Int Wound J. 2019 Feb;16(1):250-255. doi: 10.1111/iwj.13019. Epub 2018 Nov 4.
5
Non-uraemic calciphylaxis (NUC) postliver transplantation.
BMJ Case Rep. 2018 Oct 24;2018:bcr-2018-226537. doi: 10.1136/bcr-2018-226537.
6
Bilateral breast calciphylaxis in a patient who survived earlier extensive tissue necrosis 5 years previously: A case report.
Int J Surg Case Rep. 2018;48:22-25. doi: 10.1016/j.ijscr.2018.04.035. Epub 2018 May 7.

本文引用的文献

1
Wound Healing in Patients With Impaired Kidney Function.
J Am Coll Clin Wound Spec. 2014 Jun 8;5(1):2-7. doi: 10.1016/j.jccw.2014.05.002. eCollection 2013 Apr.
2
Evolving calciphylaxis--what randomized, controlled trials can contribute to the capture of rare diseases.
Clin J Am Soc Nephrol. 2015 May 7;10(5):726-8. doi: 10.2215/CJN.03350315. Epub 2015 Apr 17.
3
The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE Trial.
Clin J Am Soc Nephrol. 2015 May 7;10(5):800-7. doi: 10.2215/CJN.10221014. Epub 2015 Apr 17.
4
Calciphylaxis: a review.
J Am Col Certif Wound Spec. 2011 Mar 27;2(4):66-72. doi: 10.1016/j.jcws.2011.03.001. eCollection 2010 Dec.
5
Sodium thiosulfate: mythical treatment for a mysterious disease?
Clin J Am Soc Nephrol. 2013 Jul;8(7):1068-9. doi: 10.2215/CJN.04990513. Epub 2013 Jun 6.
6
Statin use and calcific uremic arteriolopathy: a matched case-control study.
Am J Nephrol. 2013;37(4):325-32. doi: 10.1159/000348806. Epub 2013 Mar 21.
7
Sodium thiosulfate therapy for calcific uremic arteriolopathy.
Clin J Am Soc Nephrol. 2013 Jul;8(7):1162-70. doi: 10.2215/CJN.09880912. Epub 2013 Mar 21.
8
A case-control study of calciphylaxis in Japanese end-stage renal disease patients.
Nephrol Dial Transplant. 2012 Apr;27(4):1580-4. doi: 10.1093/ndt/gfr658. Epub 2011 Nov 25.
9
Evolution of treatment strategies for calciphylaxis.
Am J Nephrol. 2011;34(5):460-7. doi: 10.1159/000332221. Epub 2011 Oct 6.
10
Sodium thiosulfate: new hope for the treatment of calciphylaxis.
Semin Dial. 2010 May-Jun;23(3):258-62. doi: 10.1111/j.1525-139X.2010.00738.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验